Author:
Kulkarni Kanchan,Atkins Frank B,Van Nostrand Douglas
Reference39 articles.
1. Spies WJ, Wojtowicz CH, Spies SM, et al. Value of post-therapy whole body 131I imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose 131I therapy. Clin Nucl Med. 1989;14:892–00.
2. Simpson WJ, Panzarella T, Carruthers JS, et al. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys. 1998;14:1063–75.
3. van Sorge-van Boxtel RA, van Eck-Smit BL, Goslings BM. Comparison of serum thyroglobulin, 131I and 201Tl scintigraphy in the prospective follow-up of differentiated thyroid cancer. Nucl Med Commun. 1993;14:365–72.
4. Lubin E, Mechlis-Frisch S, Zatz S, et al. Serum thyroglobulin and iodine-131 whole body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med. 1994;35:257–62.
5. Sutter CW, Masilungan B, Stadalnik RC. False-positive results of 131I whole body scans in patients with thyroid cancer. Semin Nucl Med. 1995;25:279–82.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献